11/24/2014 - 9:52am

Dr. Reddy's Labs on Monday announced the launch of docetaxel injection USP in 20-mg and 80-mg dosage strengths. The drug is the generic version of Taxotere.

 

11/21/2014 - 12:16pm

A study being published in Annals of Internal Medicine suggests that people with atrial fibrillation who take NSAIDs may be at risk for serious bleeding or thromboembolisms. 

11/20/2014 - 3:48pm

Purdue Pharma on Thursday announced that the Food and Drug Administration approved Hysingla ER (hydrocodone bitartrate) extended‐release tablets CII, a once‐daily, single‐entity medication formulated using Purdue’s proprietary extended‐release solid oral platform, Resistec.

11/20/2014 - 1:06pm

Amneal Pharmaceuticals on Thursday announced the launch of Lopreeza (estradiol/norethindrone acetate) tablets in 0.5-mg and 1-mg dosage strengths. The product is the first authorized generic of Activella from Novo Nordisk.

 

11/20/2014 - 10:42am

Dr. Reddy’s Labs announced Thursday that it has launched a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the U.S. market.

11/20/2014 - 10:26am

Rite Aid on Thursday announced Quality Independent Physicians, based in Louisville, Ky., as the latest healthcare provider to join its Rite Aid Health Alliance initiative. 

 

11/20/2014 - 10:18am

The Consumer Healthcare Products Association board of directors on Wednesday announced changes to CHPA’s voluntary guidelines addressing dosing of liquid pediatric over-the-counter medicines.

11/20/2014 - 9:47am

CVS Health announced on Thursday that the company and its foundation has committed to invest more than $1 million in grants to support tobacco cessation and prevention programs.

11/20/2014 - 9:13am

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.